Pfizer (PFE),Protalix (PLX) Report Taliglucerase Alfa Denied Marketing Approval by EC
Go back to Pfizer (PFE),Protalix (PLX) Report Taliglucerase Alfa Denied Marketing Approval by EC| Pfizer Inc. (NYSE: PFE) | Delayed: 28.07 +0.28 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.77 | 52 Week Low | $28.25 | |||
| Day High | $28.43 | P/E | 17.01 | |||
| Day Low | $27.66 | EPS | $1.65 | |||
| Volume | 37,094,598 | |||||
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.38 | 52 Week High | $1.11 | |||
| Open | $2.39 | 52 Week Low | $0.41 | |||
| Day High | $2.44 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $-0.29 | |||
| Volume | 648,550 | |||||
